RENAISSANCE TECHNOLOGIES LLC

Position in LEXX — Lexaria Bioscience Corp.

CIK 1037389 NEW YORK, NY

Position in LEXX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$9,240

-$3,474 QoQ

Shares Held

1,100

+1.2% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 31 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,825,954 across 312 Biotechnology names. LEXX ranks #308 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,240	16,500	+1.2%	Shares	Sole	2026-08-13
2026-03-31	$12,714	16,300	+4.5%	Shares	Sole	2026-05-14
2025-12-31	$9,625	15,600	+54.5%	Shares	Sole	2026-02-12
2025-09-30	$9,625	10,100	-55.7%	Shares	Sole	2025-11-13
2024-06-30	$63,384	22,800	+76.7%	Shares	Sole	2024-08-09
2023-09-30	$12,900	12,900	+20.6%	Shares	Sole	2023-11-14
2023-06-30	$7,811	10,700	-21.3%	Shares	Sole	2023-08-11
2023-03-31	$36,992	13,600	+18.3%	Shares	Sole	2023-05-12
2022-12-31	$28,290	11,500	-3.4%	Shares	Sole	2023-02-13
2022-09-30	$29,155	11,900	+3.5%	Shares	Sole	2022-11-14
2022-06-30	$34,270	11,500	-33.1%	Shares	Sole	2022-08-12
2021-06-30	$120,400	17,200	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.